Genenta Science Statistics

Total Valuation

Genenta Science has a market cap or net worth of $72.61 million. The enterprise value is $59.50 million.

Market Cap	72.61M
Enterprise Value	59.50M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Genenta Science has 18.29 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	n/a
Shares Outstanding	18.29M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	28.25%
Owned by Institutions (%)	6.85%
Float	11.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.03
P/TBV Ratio	5.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.89

Current Ratio	6.89
Quick Ratio	6.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -54.13% and return on invested capital (ROIC) is -37.04%.

Return on Equity (ROE)	-54.13%
Return on Assets (ROA)	-32.84%
Return on Invested Capital (ROIC)	-37.04%
Return on Capital Employed (ROCE)	-76.74%
Revenue Per Employee	n/a
Profits Per Employee	-$659,081
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.44% in the last 52 weeks. The beta is 0.71, so Genenta Science's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	+8.44%
50-Day Moving Average	3.92
200-Day Moving Average	4.31
Relative Strength Index (RSI)	50.48
Average Volume (20 Days)	48,827

Short Selling Information

Short Interest	2,534
Short Previous Month	3,377
Short % of Shares Out	0.01%
Short % of Float	n/a
Short Ratio (days to cover)	0.21

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.11M
Pretax Income	-12.73M
Net Income	-9.23M
EBITDA	-10.06M
EBIT	-10.11M
Earnings Per Share (EPS)	-$0.51

Full Income Statement

Balance Sheet

The company has $13.11 million in cash and n/a in debt, giving a net cash position of $13.11 million or $0.72 per share.

Cash & Cash Equivalents	13.11M
Total Debt	n/a
Net Cash	13.11M
Net Cash Per Share	$0.72
Equity (Book Value)	12.94M
Book Value Per Share	0.71
Working Capital	12.81M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.46 million and capital expenditures -$4,626, giving a free cash flow of -$6.18 million.

Operating Cash Flow	-6.46M
Capital Expenditures	-4,626
Free Cash Flow	-6.18M
FCF Per Share	-$0.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genenta Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	n/a
Earnings Yield	-12.71%
FCF Yield	-8.52%

Analyst Forecast

The average price target for Genenta Science is $25.00, which is 529.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	529.72%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1